Vaccination for pancreatic ductal adenocarcinoma: a hard nut to crack

Salas-Benito, D., Melero, I., Ponz-Sarvise, M. (July 2019) Vaccination for pancreatic ductal adenocarcinoma: a hard nut to crack. Clin Cancer Res, 25 (18). pp. 5435-5437. ISSN 1078-0432 (Print)1078-0432

URL: https://www.ncbi.nlm.nih.gov/pubmed/31315885
DOI: 10.1158/1078-0432.ccr-19-1753

Abstract

No immunotherapy strategy is yet offering consistent results against Pancreatic ductal adenocarcinoma (PDAC). A randomized clinical trial testing repeated immunization with a Listeria monocytogenes-based vaccine encoding for mesothelin in combination with a GM-CSF-transfected allogeneic pancreatic cell vaccine reports no survival benefit for the vaccinated patients.

Item Type: Paper
Subjects: diseases & disorders > cancer > cancer types > pancreatic cancer
CSHL Authors:
Communities: CSHL labs > Tuveson lab
Depositing User: Matthew Dunn
Date: 17 July 2019
Date Deposited: 09 Aug 2019 15:08
Last Modified: 18 Oct 2019 18:49
Related URLs:
URI: http://repository.cshl.edu/id/eprint/38216

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving